A Study of Revaree Plus in People With Breast Cancer
NCT07042581
This study is recruiting at 7 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to find out whether Revaree Plus is effective at improving vaginal health for people who are having symptoms of vaginal dryness during breast cancer treatment.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Breast Cancer
- Stage 0 Breast Cancer
- Stage I Breast Cancer
- Stage II Breast Cancer
- Stage III Breast Cancer
- Stage 0 Breast Carcinoma
- Stage II Breast Carcinoma
- Stage III Breast Carcinoma
- Hormone-receptor-positive Breast Cancer
- Hormone Receptor Positive Breast Carcinoma
- Hormone Receptor Positive Malignant Neoplasm of Breast
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 18 years and older
- Sex
- Female
- Healthy volunteers
- Not accepted
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Last updated on ClinicalTrials.gov
- February 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New Jersey · 3
- Memorial Sloan Kettering Basking Ridge (Consent Only) · Basking Ridge, NJ
- Memorial Sloan Kettering Monmouth (Consent Only) · Middletown, NJ
- Memorial Sloan Kettering Bergen (Consent Only) · Montvale, NJ
New York · 4
- Memorial Sloan Kettering Cancer Center Suffolk-Commack (Consent Only) · Commack, NY
- Memorial Sloan Kettering Westchester (Consent Only) · Harrison, NY
- Memorial Sloan Kettering Cancer Center · New York, NY
- Memorial Sloan Kettering Nassau (Consent Only) · Uniondale, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.